Arca
Skip to content
Tools
Tools

TSHR: Thyrotropin receptor

Receptor for the thyroid-stimulating hormone (TSH) or thyrotropin.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on TSHR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 1
  • Other 1

Approved2

  • Thyrotropin
  • Thyrotropin alfa

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        ThyrotropinApprovedRegeneronOtherAgonistThyroid stimulating hormone receptor agonist31
        Thyrotropin alfaApprovedSanofiProtein or peptideAgonistThyroid stimulating hormone receptor agonist12

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 16 in all, from ClinicalTrials.gov.
        Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura PatientsThyrotropin—Not yet recruitingSohag UniversityOct 28, 2026
        Thyroid-Stimulating Hormone Receptor (TSHR) Blockade With REGN24493 in Adult Participants With Graves' Disease (GD)ThyrotropinPhase 1Not yet recruitingRegeneron PharmaceuticalsOct 6, 2026
        Acute Endocrine Responses to Aerobic and Anaerobic Exercise in Sedentary Women: A Comparative Analysis of Thyroid Hormones and CortisolThyrotropinNot applicableRecruitingAssoc. Prof. Dr. Özgür EKENSep 16, 2026
        Subclinical Hypothyroidism and Disease Activity in Rheumatoid ArthritisThyrotropin—Not yet recruitingAssiut UniversityAug 31, 2026
        Hypothyroidism and Liver Fibrosis Severity in MASLDThyrotropin—Not yet recruitingAssiut UniversityAug 28, 2026
        Evaluation of Levothyroxine Replacement Therapy After Total Thyroidectomy Using a Smart WristbandThyrotropinNot applicableRecruitingYeditepe University HospitalJul 29, 2026
        Internal Organ and Musculoskeletal Assessment in Hypothyroidism (HYPOMORPH)Thyrotropin—RecruitingAndijan State Medical InstituteJul 16, 2026
        First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.Thyrotropin alfaPhase 1RecruitingAllterum Therapeutics, IncMay 14, 2026
        Levothyroxine Treatment on Cardiac Function in Children With Subclinical HypothyroidismThyrotropinNot applicableRecruitingTanta UniversityFeb 6, 2026
        Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist TreatmentThyrotropin alfaNot applicableRecruitingNanjing UniversityAug 19, 2025
        Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)Thyrotropin alfaPhase 4RecruitingFundacion Clinic per a la Recerca BiomédicaMar 26, 2025
        Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E MutationThyrotropin alfaPhase 2RecruitingCity of Hope Medical CenterJun 4, 2024
        Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid CancerThyrotropin alfaNot applicableRecruitingNanjing First Hospital, Nanjing Medical UniversityMay 28, 2024
        Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I TreatmentThyrotropin alfaNot applicableRecruitingNanjing First Hospital, Nanjing Medical UniversityMay 8, 2024
        Study of CM310 in Patients With Uncontrolled Seasonal Allergic RhinitisThyrotropin alfaPhase 2RecruitingBeijing Tongren HospitalMar 8, 2024
        CASE 1320: RAI Uptake and Serum Prolactin in Thyroid CancerThyrotropin alfa—Active, not recruitingThe Cleveland ClinicAug 3, 2020

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        Hypothyroidism due to TSH receptor mutations
        0.83
        Familial hyperthyroidism due to mutations in TSH receptor
        0.81
        Hypothyroidism
        0.79
        Familial gestational hyperthyroidism
        0.72
        Thyroid gland disorder
        0.71
        Myxedema
        0.66
        Congenital hypothyroidism
        0.59
        Hyperthyroidism
        0.55
        Hereditary disease
        0.50
        Thyroid hypoplasia
        0.47

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1963, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P16473, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.